Skip to main content
. 2020 Sep 12;148(4):868–875. doi: 10.1002/ijc.33266

FIGURE 2.

FIGURE 2

Annualised proportion of patients prescribed ipilimumab, pembrolizumab, nivolumab and ipinivo linked to patient access, determined by NICE TA guidance publications [Color figure can be viewed at wileyonlinelibrary.com]